Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effects of inoculation with attenuated autologous T cells in patients with rheumatoid arthritis.
Biomarkers of treatment response in multiple sclerosis.
RORγt, but not T-bet, overexpression exacerbates an autoimmune model for multiple sclerosis.
Biological and nonbiological complex drugs for multiple sclerosis in Latin America: regulations and risk management.
Association of Missense Mutations of Mediterranean Fever (MEFV) Gene with Multiple Sclerosis in Turkish Population.
T Cell Epitope Mapping of JC Polyoma Virus-Encoded Proteome Reveals Reduced T Cell Responses in HLA-DRB1*04:01+ Donors.
Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element.
The Management of Pediatric Multiple Sclerosis.
Multiple sclerosis lesion formation and early evolution revisited: A weekly high-resolution magnetic resonance imaging study.
Multiple sclerosis impairs regional functional connectivity in the cerebellum.
Current status of myelin replacement therapies in multiple sclerosis.
Hierarchical conditional random fields for detection of gad-enhancing lesions in multiple sclerosis.
Identifying the Start of Multiple Sclerosis Injury: A Serial DTI Study.
Urinary tract infections in multiple sclerosis: under-diagnosed and under-treated? A clinical audit at a large University Hospital.
ApoTransferrin: Dual Role on Adult Subventricular Zone-Derived Neurospheres.
HMGB1 in Development and Diseases of the Central Nervous System.
High-Affinity Binding of Remyelinating Natural Autoantibodies to Myelin-Mimicking Lipid Bilayers Revealed by Nanohole Surface Plasmon Resonance.
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice.
Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography.
Strength-duration time constant in peripheral nerve: no abnormality in multiple sclerosis.
Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?
2-BFI ameliorates EAE-induced mouse spinal cord damage: Effective therapeutic time window and possible mechanisms.
Aging and multiple sclerosis.
Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study.

Pages